Europe Syndromic Multiplex Diagnostic Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices Europe Syndromic Multiplex Diagnostic Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Europe Syndromic Multiplex Diagnostic Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Medical Devices
  • Apr 2025
  • Europe
  • 350 Pages
  • No of Tables: 448
  • No of Figures: 41
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Europe Syndromic Multiplex Diagnostic Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Europe Syndromic Multiplex Diagnostic Market size in 2024 - 1.17 and 2032 - 2.19, highlighting the projected market growth. USD 1.17 Billion USD 2.19 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 1.17 Billion
Diagram Market Size (Forecast Year)
 USD 2.19 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • F. Hoffmann-La Roche Ltd
  • DiaSorin S.p.A
  • BIOMÉRIEUX
  • Thermo Fisher Scientific Inc.
  • QIAGEN

Europe Syndromic Multiplex Diagnostic Market Segmentation, By Product Type (Accessories & Consumables, Instruments, and Software & Services), Infection Type (Viral, Bacterial, Fungal, Parasites, and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Meningitis, Childhood Infections, Immunosuppression, Tropical Fever, Hepatitis, Eye Infections, and Other Diseases), End User (Hospitals, Clinical Laboratories, Physician Offices, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2032

Syndromic Multiplex Diagnostic Market

Syndromic Multiplex Diagnostic Market Analysis

The syndromic multiplex diagnostic market is experiencing significant growth due to increasing demand for rapid, accurate diagnostics and the rise of infectious diseases. These diagnostic platforms allow simultaneous detection of multiple pathogens, improving efficiency and patient outcomes. Key drivers include advancements in molecular diagnostics, government investments in healthcare infrastructure, and growing awareness of personalized medicine. In addition, the COVID-19 pandemic accelerated the adoption of multiplex diagnostic systems. Leading market players are focusing on product innovations and expanding their regional presence, further enhancing market competitiveness and contributing to overall growth in Europe’s healthcare sector.

Syndromic Multiplex Diagnostic MarketSyndromic Multiplex Diagnostic Market

Syndromic Multiplex Diagnostic Market Size

The Europe syndromic multiplex diagnostic market is expected to reach USD 2.19 billion by 2032 from USD 1.17 billion in 2024, growing at a CAGR of 8.2% in the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Syndromic Multiplex Diagnostic Market Trends

“Rise of Point-of-Care Testing in Syndromic Multiplex Diagnostics”

Point-of-Care Testing is a significant trend in the Europe syndromic multiplex diagnostic market. The increasing demand for rapid, on-site diagnostics is driving the adoption of portable and easy-to-use multiplex testing devices. These point-of-care solutions allow for faster detection of multiple pathogens, improving patient outcomes by enabling timely treatment decisions. This trend is particularly beneficial in emergency settings, rural areas, and during outbreaks, where quick diagnosis is crucial. With advancements in miniaturized diagnostic technology, these devices are becoming more accurate, cost-effective, and user-friendly, significantly expanding their role in healthcare delivery across Europe.

Report Scope and Syndromic Multiplex Diagnostic Market Segmentation                   

Attributes

Syndromic Multiplex Diagnostic Key Market Insights

Segments Covered
  • By Product Type: Accessories & Consumables, Instruments, and Software & Services
  • By Infection Type: Viral, Bacterial, Fungal, Parasites, and Others
  • By Disease: Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Meningitis, Childhood Infections, Immunosuppression, Tropical Fever, Hepatitis, Eye Infections, and Other Diseases
  • By End User: Hospitals, Clinical Laboratories, Physician Offices, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others
  • By Distribution Channel: Direct Tender, Retail Sales, and Others

Countries Covered

Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Sweden, Poland, Denmark, Norway, Finland, and Rest of Europe

Key Market Players

F. Hoffmann-La Roche Ltd (Switzerland), DiaSorin S.p.A (Italy), BIOMÉRIEUX (France), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), BD Veritor (BD) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Seegene Inc. (South Korea), Hologic, Inc. (U.S.), Bosch Healthcare Solutions GmbH (Germany), Abbott (U.S.), QuidelOrtho Corporation (U.S.), Biocartis (Belgium), and PathoFinder (Netherlands) among others

Market Opportunities

  • Advancements in AI & automation
  • Rising aging population in Europe

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and PESTLE analysis.

Syndromic Multiplex Diagnostic Market Definition

The Europe syndromic multiplex diagnostic market refers to the diagnostic tests and platforms that simultaneously detect multiple pathogens or biomarkers in a single sample, enabling the rapid diagnosis of various diseases, including infectious diseases, cancer, and genetic disorders. These diagnostics allow healthcare providers to quickly identify the cause of a patient's symptoms, improving treatment outcomes and reducing healthcare costs. The market is driven by technological advancements in molecular diagnostics, increasing demand for faster and more accurate tests, and a growing focus on personalized medicine.

Syndromic Multiplex Diagnostic Market Dynamics

Drivers

  • Rising Prevalence of Infectious Diseases

The burden of infectious diseases is rapidly increasing across the Europe. Various types of pathogenic microorganisms are associated with infectious diseases such as viruses, fungal, bacteria and parasites. As infectious diseases become more frequent and complex, the need for more efficient, rapid, and comprehensive diagnostic tools becomes critical. Syndromic multiplex diagnostics offer a solution by allowing the simultaneous detection of multiple pathogens in a single test, a capability that is becoming increasingly essential in the face of new and re-emerging infectious diseases. Increasing cases of infectious diseases which is enhancing the syndromic multiplex diagnostic rate, due to which growing prevalence of infectious diseases is propelling the market growth.

For instance,

In December 2023, WHO reported that, seasonal respiratory infections surging across the WHO European Region, with RSV, COVID-19, influenza, and Mycoplasma pneumoniae driving increased hospitalizations. Young children, older adults, and individuals with underlying conditions face higher risks. Strengthening preventive measures, including vaccination and hygiene practices, remains crucial in mitigating illness and reducing healthcare system burdens.

The rising prevalence of infectious diseases across Europe drives the demand for advanced diagnostic solutions. Syndromic multiplex diagnostics, with their ability to detect multiple pathogens in one test, address the growing need for rapid and accurate disease identification. This trend significantly boosts market growth.

  • Rising Adoption of Molecular Diagnostics Techniques

Molecular diagnostics is a rapidly evolving and transformative field that is revolutionizing disease detection, treatment, and research. It enables the precise identification of infectious diseases, often at an early stage. In molecular diagnostics, multiplex PCR (Polymerase Chain Reaction) panel assays are used to diagnose infectious diseases by simultaneously detecting genetic material from various pathogens. These assays can identify different types of microorganisms, including fungi, parasites, bacteria, and viruses, across multiple taxonomic levels.

With the growing reliance on molecular diagnostic techniques, pathogen detection has become more comprehensive and efficient. Multiplex PCR and advanced sequencing technologies play a crucial role in enabling rapid and accurate disease diagnosis, ultimately improving patient outcomes. The increasing demand for precise and timely healthcare solutions is driving innovation in the market, leading to enhanced clinical decision-making and more effective treatment strategies.

For instance,

In March 2024, as per an article published by Elsevier Inc, the growing adoption of molecular diagnostic techniques, especially PCR-based methods, has significantly transformed the way infectious diseases are diagnosed. FDA-approved multiplex PCR panels are now capable of detecting pathogens responsible for respiratory infections with high sensitivity and fast results. These panels not only enable timely and accurate diagnoses but also help guide antimicrobial treatment decisions, ultimately improving clinical outcomes and optimizing patient care.

The increasing use of molecular diagnostics and syndromic multiplex techniques is reshaping healthcare by providing fast, precise results for various infections. These innovations streamline diagnostics, reduce costs, and enhance treatment accuracy, making them essential tools for addressing complex diseases and improving patient care worldwide.

Syndromic Multiplex Diagnostic Market

Opportunities

  • Advancements in Ai & Automation

Advancements in AI and automation are transforming the Europe syndromic multiplex diagnostic market by enhancing processes’ accuracy, efficiency, and speed. AI-driven algorithms are being integrated into syndromic diagnostic platforms to analyze complex datasets, identify pathogens more precisely, and reduce the likelihood of false positives or negatives. Machine learning models are streamlining result interpretation, enabling faster clinical decision-making, and minimizing human errors. Automation further optimizes sample handling, processing, and result generation, reducing the dependency on skilled personnel and improving overall laboratory workflow efficiency. AI-powered predictive analytics are also aiding in early disease detection and outbreak monitoring, allowing healthcare providers to take proactive measures. Integrating automation with syndromic multiplex diagnostics ensures consistent and high-throughput testing. This is especially beneficial for large healthcare facilities and diagnostic centers handling high patient volumes. As AI continues to evolve, its role in refining syndromic diagnostic accuracy and reducing time is becoming increasingly critical.

For instance,

In December 2024, as per an article outlined by NCBI, the future advancements in syndromic multiplex diagnostics may involve integrating Rapid multiplex molecular syndromic panels (RMMSP) with predictive artificial intelligence, improving diagnostic accuracy and optimizing the management of critically ill, infected patients. AI-driven automation can enhance result interpretation, reduce human errors, and streamline workflows.AI automation and molecular innovations will redefine diagnostics, increasing efficiency and precision while improving patient care. This evolution will unlock new possibilities for syndromic multiplex diagnostics, driving advancements in disease detection and healthcare outcomes.

AI-driven algorithms improve pathogen detection, reduce errors, and accelerate clinical decisions. Automation streamlines sample processing and minimizes reliance on skilled staff. AI-powered analytics aid in early disease detection, boosting diagnostic capacity. These advancements present a significant opportunity by enhancing efficiency and accessibility, fostering market expansion.

  • Rising Aging Population in Europe

As people age, their immune systems weaken, making them more susceptible to infections, increasing the demand for advanced diagnostic technologies. These solutions enable early detection, timely treatment, and improved healthcare outcomes, driving market expansion and innovation in diagnostic solutions.

For instance,

In February 2025, as per the information published by Eurostat an official website of European Union, as of January 1, 2024, the EU population was estimated at 449.3 million, with over 21.6% aged 65 and older, and a median age of 44.7 years. These growing elderly demographic increases demand for advanced diagnostics, acting as opportunity for the market growth.

With over 21% of Southern Europe’s population already aged 65+, and the EU’s elderly population projected to nearly double by 2060, the demand for advanced diagnostics is set to rise. As aging weakens the immune system, increasing susceptibility to infections, syndromic multiplex diagnostics will play a vital role in early detection and timely treatment, creating opportunity for market expansion.

Restraints/Challenges

  • High Cost of Diagnostic Products

Smaller healthcare facilities and under-resourced settings struggle to adopt these advanced technologies due to financial constraints. The syndromic multiplex diagnostic also includes fully-automated, random access, multiplex testing for clinical diagnostic assays for rapid and accurate diagnostic test, however all this product are expensive to be purchased by the end users which is hampering the growth of the market.

The instruments which are used in the syndromic multiplex diagnostic are require high maintenance cost also it is very expensive in the nature same as with the reagents & consumables, for this reason high cost of diagnostic products is acting as a restraint for hampering the growth of Europe syndromic multiplex diagnostic market.

  • Challenges in Detecting Resistance Mechanisms

While syndromic panels offer rapid and comprehensive pathogen identification, they often fail to detect specific antimicrobial resistance mechanisms, crucial for determining the most appropriate antibiotic therapy. This limitation increases the risk of inappropriate or ineffective treatments, potentially contributing to the growing problem of antimicrobial resistance. Infections caused by multidrug-resistant organisms require precise identification of resistance markers to ensure timely and targeted interventions, yet the inability of some syndromic tests to provide this information hinders clinical decision-making. Healthcare providers may still need to rely on additional conventional testing methods, increasing diagnostic time and costs, which reduces the overall efficiency of syndromic testing. As regulatory bodies and healthcare institutions emphasize the importance of antimicrobial stewardship programs, the need for enhanced syndromic diagnostic solutions that effectively detect resistance mechanisms becomes more pressing. The inability to fully address this issue limits the adoption of syndromic panels and slows the growth of the Europe syndromic multiplex diagnostic market.

For instance,

In February 2023, as per an article by NCBI, Genotypic tests struggled to detect non-enzymatic resistance mechanisms like porin loss or efflux pump upregulation and only predicted resistance, not susceptibility. Their high cost and limited clinical validation raise concerns about utility, especially for Gram-negative bacteria. These limitations pose a significant challenge for the market, restricting its effectiveness in guiding precise antimicrobial therapy.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Syndromic Multiplex Diagnostic Market Scope

The market is segmented into five notable segments based on the product type, infection type, disease, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Accessories & Consumables
    • Panels
      • Multiplex Respiratory Panels
        • Multiplex Lower Respiratory Panels
          • Pneumonia (PN)/Pneumonia Plus (PNPLUS) Panels
          • Unyvero LRT Test
          • Other
        • Multiplex Upper Respiratory Panels
          • Respiratory Viral Panel
          • Respiratory Pathogen Panel (RPP)/Respiratory Panel 2 (RP2)
          • Respiratory Panel EZ (Clia-Waived)
          • Respiratory Pathogens Flex Test (RP Flex)
          • Other Panels
        • Multiplex GI Panels
          • GI Pathogen Panel (GPP)
          • Enteric Bacterial Panel
          • Enteric Viral Panel
          • Enteric Parasite Panel
          • Extended Enteric Bacterial Panel
          • Other Panels
        • Multiplex Blood Culture Panels
          • BCID Panel (Broad-Spectrum Pathogen Identification)
          • BCID-GP Panel (Gram-Positive Bacteria Panel)
          • BCID-GN Panel (Gram-Negative Bacteria Panel)
          • BCID-FP Panel (Fungal Pathogen Detection)
          • Gram-Positive Blood Culture Test (BC-GP)
          • Blood Culture Test (BC-GN)
          • Candida Panel
          • Bacteria Panel
          • Phenotest BC
          • Other Panels
      • Meningitis/Encephalitis Syndromic Panel
      • STI Test Panels
      • Other Syndromic Multiplex Diagnostic Panels
    • Others
  • Instruments
  • Software & Services

Infection Type

  • Viral
    • Rhinovirus
    • Coronavirus
    • Rotavirus
    • Adenovirus
    • Others
  • Bacterial
    • Staphylococcus
    • Pneumoniae
    • Bordetella Pertussis
    • Others
  • Fungal
  • Parasites
  • Others

Disease

  • Respiratory Infections
  • Gastroenteritis
  • Sexually Transmitted Infections
  • Meningitis
  • Childhood Infections
  • Immunosuppression
  • Tropical Fever
  • Hepatitis
  • Eye Infections
  • Other Diseases

End User

  • Hospitals
    • By Type
      • Public
      • Private
    • By Level
      • Tier 1
      • Tier 2
      • Tier 3
  • Clinical Laboratories
    • Private
    • Public
  • Physician Offices
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales
    • Online
    • Offline
  • Others

Syndromic Multiplex Diagnostic Market

Syndromic Multiplex Diagnostic Market Regional Analysis

The market is analyzed and market size insights and trends are provided by product type, infection type, disease, end user, and distribution channel as referenced above.

Germany is projected to lead and growing rapidly in the market due to increasing demand for fast and accurate diagnostic results and strategic initiatives taken by market players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Syndromic Multiplex Diagnostic Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Syndromic Multiplex Diagnostic Market Leaders Operating in the Market Are:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • DiaSorin S.p.A (Italy)
  • BIOMÉRIEUX (France)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN (Netherlands)
  • BD Veritor (BD) (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Danaher Corporation (U.S.)
  • Seegene Inc. (South Korea)
  • Hologic, Inc. (U.S.)
  • Bosch Healthcare Solutions GmbH (Germany)
  • Abbott (U.S.)
  • QuidelOrtho Corporation (U.S.)
  • Biocartis (Belgium)
  • PathoFinder (Netherlands)

Latest Developments in Syndromic Multiplex Diagnostic Market

  • In November 2024, Roche entered into an agreement to acquire Poseida Therapeutics for approximately USD 1 billion. This acquisition enhances Roche's capabilities in allogeneic cell therapies, particularly for oncology, immunology, and neurology. It aims to accelerate the development of off-the-shelf CAR-T therapies, benefiting patients by increasing treatment access and improving clinical outcomes. The transaction is expected to close in the first quarter of 2025
  • In September 2024, Roche launched the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses. New TAGS (Temperature-Activated Generation of Signal) technology enabled up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers cobas 5800, 6800 and 8800
  • In March 2023, Roche announced that the U.S. FDA Oncologic Drugs Advisory Committee voted in favor of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma (DLBCL). This combination showed a significant improvement in progression-free survival compared to the standard R-CHOP regimen, offering a promising first-line treatment option for DLBCL patients. The decision is expected to improve outcomes for patients with this aggressive cancer, which has seen limited progress in treatment over the past 20 years
  • In March 2022, MDiaSorin’s Luminex received CE marking for its xMAP NxTAG Gastrointestinal Pathogen Panel (GPP), a multiplex test detecting 16 bacterial, viral, and parasitic pathogens in stool samples. Designed for the MAGPIX System, it delivers same-day results, enhancing rapid diagnosis, antibiotic stewardship, and high-throughput testing for clinical laboratories across Europe
  • In May 2023, DiaSorin S.p.A. strengthens its partnership with MeMed by signing a distribution agreement for the MeMed BV test in Italy. This test, integrated with AI, differentiates bacterial from viral infections, aiding antibiotic decisions. Validated globally, it enhances patient management and supports efforts to combat antimicrobial resistance

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 INDUSTRY INSIGHTS

4.4 TECHNOLOGY ROADMAP

5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES

6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES

6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS

6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS

 

6.2 RESTRAINTS

6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS

6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS

6.3 OPPORTUNITIES

6.3.1 ADVANCEMENTS IN AI & AUTOMATION

6.3.2 RISING AGING POPULATION IN EUROPE

6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS

6.4 CHALLENGES

6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS

6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE

7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 ACCESSORIES & CONSUMABLES

7.2.1 PANELS

7.2.1.1 MULTIPLEX RESPIRATORY PANELS

7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS

7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS

7.2.1.1.3 UNYVERO LRT TEST

7.2.1.1.4 OTHER

7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS

7.2.1.2.1 RESPIRATORY VIRAL PANEL

7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2)

7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED)

7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX)

7.2.1.2.5 OTHER PANELS

7.2.1.3 MULTIPLEX GI PANELS

7.2.1.3.1 GI PATHOGEN PANEL (GPP)

7.2.1.3.2 ENTERIC BACTERIAL PANEL

7.2.1.3.3 ENTERIC VIRAL PANEL

7.2.1.3.4 ENTERIC PARASITE PANEL

7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL

7.2.1.3.6 OTHER PANELS

7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS

7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION)

7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL)

7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL)

7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION)

7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP)

7.2.1.4.6 BLOOD CULTURE TEST (BC-GN)

7.2.1.4.7 CANDIDA PANEL

7.2.1.4.8 BACTERIA PANEL

7.2.1.4.9 PHENOTEST BC

7.2.1.4.10 OTHER PANELS

7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL

7.2.1.6 STI TEST PANELS

7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS

7.3 INSTRUMENTS

7.4 SOFTWARE & SERVICES

8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

8.1 OVERVIEW

8.2 VIRAL

8.2.1 RHINOVIRUS

8.2.2 CORONAVIRUS

8.2.3 ROTAVIRUS

8.2.4 ADENOVIRUS

8.2.5 OTHERS

8.3 BACTERIAL

8.3.1 STAPHYLOCOCCUS

8.3.2 PNEUMONIA

8.3.3 BORDETELLA PERTUSSIS

8.3.4 OTHERS

8.4 FUNGAL

8.5 PARASITES

8.6 OTHERS

9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

9.1 OVERVIEW

9.2 RESPIRATORY INFECTIONS

9.3 GASTROENTERITIS

9.4 SEXUALLY TRANSMITTED INFECTIONS

9.5 MENINGITIS

9.6 CHILDHOOD INFECTIONS

9.7 IMMUNOSUPPRESSION

9.8 TROPICAL FEVER

9.9 HEPATITIS

9.1 EYE INFECTIONS

9.11 OTHER DISEASES

10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 BY TYPE,

10.2.1.1 PRIVATE

10.2.1.2 PUBLIC

10.2.2 BY LEVEL

10.2.2.1 TIER 1

10.2.2.2 TIER 2

10.2.2.3 TIER 3

10.3 CLINICAL LABORATORIES

10.3.1 BY TYPE

10.3.1.1 PRIVATE

10.3.1.2 PUBLIC

10.4 PHYSICIAN OFFICES

10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.6 RESEARCH INSTITUTES

10.7 OTHERS

11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.3.1 ONLINE

11.3.2 OFFLINE

11.4 OTHERS

12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES

12.1 EUROPE

12.1.1 GERMANY

12.1.2 U.K.

12.1.3 FRANCE

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 NETHERLANDS

12.1.8 TURKEY

12.1.9 BELGIUM

12.1.10 SWEDEN

12.1.11 POLAND

12.1.12 DENMARK

12.1.13 NORWAY

12.1.14 FINLAND

12.1.15 REST OF EUROPE

13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 F. HOFFMANN-LA ROCHE LTD

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENTS

15.2 DIASORIN S.P.A

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 SOULUTION PORTFOLIO

15.2.4 RECENT DEVELOPMENT

15.3 BIOMERIEUX

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS/NEWS

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 QIAGEN

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

 

15.6 ABBOTT

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS/NEWS

15.7 BD VERITOR (BD)

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 BIOCARTIS

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIO-RAD LABORATORIES, INC.

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.1 BOSCH HEALTHCARE SOLUTIONS GMBH

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 DANAHER CORPORATION

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 HOLOGIC, INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENTS/NEWS

15.13 PATHOFINDER

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

 

15.14 QUIDELORTHO CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENTS/NEWS

15.15 SEEGENE INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 COST OF MULTIPLEX DIAGNOSTIC PRODUCT IN USD

TABLE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 3 EUROPE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 4 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 6 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 7 EUROPE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 10 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 11 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 13 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 14 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 15 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 16 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 17 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 19 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 26 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 27 EUROPE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 31 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 GERMANY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 34 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 35 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 36 GERMANY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 37 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 38 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 39 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 40 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 42 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 43 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 45 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 46 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 48 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 49 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 GERMANY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 GERMANY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 52 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 53 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 54 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 56 GERMANY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 58 GERMANY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 59 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 U.K. ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 63 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 64 U.K. MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 67 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 68 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 70 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 71 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 73 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 74 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 77 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 U.K. VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 79 U.K. BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 80 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 81 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 82 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 84 U.K. CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 86 U.K. RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 FRANCE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 91 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 92 FRANCE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 94 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 95 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 96 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 98 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 99 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 101 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 102 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 104 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 105 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 FRANCE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 107 FRANCE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 109 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 110 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 112 FRANCE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 114 FRANCE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 116 ITALY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 120 ITALY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 122 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 123 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 124 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 127 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 129 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 130 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 132 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 133 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 ITALY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 ITALY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 136 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 137 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 138 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 139 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 140 ITALY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 142 ITALY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 143 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 144 SPAIN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 147 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 148 SPAIN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 149 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 150 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 151 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 152 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 154 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 155 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 156 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 157 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 158 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 159 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 160 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 161 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 SPAIN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 SPAIN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 164 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 165 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 166 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 168 SPAIN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 170 SPAIN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 171 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 172 RUSSIA ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 175 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 176 RUSSIA MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 178 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 179 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 180 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 182 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 183 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 185 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 186 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 188 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 189 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 RUSSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 191 RUSSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 192 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 193 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 194 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 195 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 196 RUSSIA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 198 RUSSIA RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 199 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 200 NETHERLANDS ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 201 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 203 NETHERLANDS MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 204 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 205 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 206 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 207 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 209 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 211 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 212 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 213 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 214 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 215 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 NETHERLANDS VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 217 NETHERLANDS BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 219 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 220 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 222 NETHERLANDS CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 224 NETHERLANDS RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 SWITZERLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 228 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 229 SWITZERLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 230 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 231 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 232 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 233 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 234 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 235 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 236 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 237 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 238 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 239 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 240 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 241 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 242 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 243 SWITZERLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 244 SWITZERLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 246 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 247 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 249 SWITZERLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 250 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 251 SWITZERLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 252 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 253 TURKEY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 254 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 255 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 256 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 257 TURKEY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 258 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 259 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 260 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 261 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 262 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 263 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 264 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 266 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 267 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 269 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 270 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 TURKEY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 TURKEY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 273 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 274 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 275 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 276 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 277 TURKEY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 279 TURKEY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 280 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 281 BELGIUM ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 282 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 283 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 284 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 285 BELGIUM MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 286 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 288 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 289 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 290 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 291 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 292 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 293 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 294 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 295 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 296 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 297 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 298 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 299 BELGIUM VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 BELGIUM BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 302 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 303 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 305 BELGIUM CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 306 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 307 BELGIUM RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 309 SWEDEN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 310 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 313 SWEDEN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 315 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 316 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 317 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 318 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 319 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 320 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 322 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 323 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 325 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 326 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 SWEDEN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 328 SWEDEN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 329 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 330 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 331 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 333 SWEDEN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 334 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 335 SWEDEN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 336 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 337 POLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 338 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 340 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 341 POLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 342 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 343 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 344 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 345 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 346 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 347 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 348 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 349 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 350 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 351 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 352 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 353 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 354 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 355 POLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 POLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 358 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 359 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 361 POLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 362 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 363 POLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 364 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 365 DENMARK ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 366 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 367 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 368 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 369 DENMARK MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 370 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 371 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 372 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 373 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 374 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 375 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 376 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 377 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 378 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 379 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 380 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 381 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 382 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 383 DENMARK VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 384 DENMARK BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 385 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 386 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 387 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 388 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 389 DENMARK CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 390 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 391 DENMARK RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 NORWAY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 394 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 396 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 397 NORWAY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 398 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 401 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 402 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 403 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 404 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 406 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 407 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 408 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 409 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 410 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 411 NORWAY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 NORWAY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 413 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 414 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 415 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 417 NORWAY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 418 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 419 NORWAY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 420 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 421 FINLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 422 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 423 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 424 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 425 FINLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 426 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 427 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 428 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 429 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 431 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 432 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 433 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 434 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 435 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 436 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 437 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)

TABLE 438 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)

TABLE 439 FINLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 440 FINLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)

TABLE 442 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 443 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 444 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)

TABLE 445 FINLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 446 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 447 FINLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 REST OF EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

List of Figure

FIGURE 1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS

FIGURE 4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COUNTRY-WISE MARKET ANALYSIS

FIGURE 5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS.

FIGURE 7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE (2024)

FIGURE 12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING PREVALENCE OF INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 15 ACCESSORIES & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 TOTAL NUMBER OF CASES OF TUBERCULOSIS IN 2022 AND 2023

FIGURE 18 TOTAL NUMBER OF CASES OF SEXUALLY TRANSMITTED INFECTIONS (STIS)

FIGURE 19 INCREASE IN THE SHARE OF THE POPULATION AGED 65 YEARS AND OVER BETWEEN 2014 AND 2024

FIGURE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2024

FIGURE 21 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)

FIGURE 22 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2024

FIGURE 25 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2025 TO 2032 (USD THOUSAND)

FIGURE 26 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2025-2032)

FIGURE 27 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE

FIGURE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2024

FIGURE 29 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2025 TO 2032 (USD THOUSAND)

FIGURE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2025-2032)

FIGURE 31 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE

FIGURE 32 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2024

FIGURE 33 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)

FIGURE 34 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2025-2032)

FIGURE 35 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE

FIGURE 36 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 37 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)

FIGURE 38 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 39 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 40 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT, 2024

FIGURE 41 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2024 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe syndromic multiplex diagnostic market size was valued at USD 1.17 billion in 2024.
The Europe syndromic multiplex diagnostic market is to grow at a CAGR of 8.2% during the forecast period of 2025 to 2032.
The Europe syndromic multiplex diagnostic market is segmented into five notable segments based on product type, infection type, disease, end user, distribution channel. On the basis of product type, the market is segmented into removable accessories & consumables, instruments, and software & services. On the basis of infection type, the market is segmented into viral, bacterial, fungal, parasites, and others. On the basis of disease, the market is segmented into respiratory infections, gastroenteritis, sexually transmitted infections, meningitis, childhood infections, immunosuppression, tropical fever, hepatitis, eye infections, and other diseases. On the basis of end user, the market is segmented into hospitals, clinical laboratories, physician offices, pharmaceutical & biotechnology companies, research institutes, and others. On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.
F. Hoffmann-La Roche Ltd (Switzerland), DiaSorin S.p.A (Italy), BIOMÉRIEUX (France), Thermo Fisher Scientific Inc. (U.S.), and QIAGEN (Germany) are the major companies in the Europe syndromic multiplex diagnostic market.

Industry Related Reports

Browse Related Pages

Browse Related Blogs

Browse Related Infographics

Browse Related Press Release

Market Statistics

Banner
Testimonial
Image
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future